§01 Browse CJC-1295

CJC-1295

CJC-1295 DAC Modified GRF 1-29
Research Compound
Growth hormone Recovery

CJC-1295 is an analog of growth-hormone-releasing hormone engineered with a Drug-Affinity Complex (DAC) that dramatically extends its biological half-life from minutes to days.

When paired with a GHRP such as GHRP-2 or Ipamorelin, it creates large, physiologically-shaped GH pulses that enhance body composition, accelerate recovery and deliver noticeable anti-aging benefits.

Protocol Why Use It Comparison Safety
Warning
Works best when combined with GHRPs · Expensive compound requiring proper storage · May cause injection site reactions
Why people use it

Users choose CJC-1295 when they want the GHRH side of the equation and a more “physiologic” story than direct hGH injection. It appeals to people who care about pulse architecture, even if the real-world result is still heavily dependent on product quality and consistent handling.

Protocol & usage

Reconstitution: Mix lyophilised powder with bacteriostatic water (1–2 mL per vial) and swirl gently until dissolved.

Administration:

  • DAC version: Inject subcutaneously 1–2 × per week
  • Mod-GRF 1-29 (no DAC): Inject 1–2 × per day, ideally alongside each GHRP shot

Storage: Rotate injection sites and keep reconstituted peptide refrigerated; discard after 30 days.

Stacking: For maximal GH output always stack with a GHRP; solo use produces only modest hormone elevations.

Timeline & expectations

DAC products feel slower and smoother. Non-DAC protocols feel more like a scheduling problem because multiple timed injections are often part of the plan. Neither should be expected to create obvious body-composition changes quickly. The feedback loop is usually sleep, recovery, edema, and longer-range body-composition trend.

Notes

Use context

CJC-1295 only makes sense once the user understands that “CJC” often refers to two different practical products. DAC versions are long acting and change baseline signaling across days. Mod-GRF 1-29 without DAC behaves more like a short GHRH pulse tool. Users who blur those together usually end up talking past the actual pharmacology.

In practice, CJC is rarely the whole story. It is usually paired with a GHRP such as Ipamorelin or GHRP-2 because the combination amplifies GH pulses more convincingly than either side alone. That pairing is the reason it has held attention for so long.

Common mistakes

The biggest mistake is talking about CJC-1295 as if DAC and Mod-GRF are interchangeable. The second is expecting solo CJC to feel like direct growth hormone. For most users it is more of a supporting signal than a dramatic stand-alone compound.

Comparison notes

Compared with Ipamorelin or GHRP-2, CJC is more like the framework than the spotlight. Compared with hGH, it offers a cleaner theoretical story with a much less predictable practical result.

Safety & monitoring
Side effects
  • Water retention, injection-site irritation, and variable response quality

  • False confidence from long action despite modest real-world output when used solo

Monitoring
  • fasting glucose if stacked heavily

  • bodyweight and edema

Avoid if
  • Users who do not understand DAC vs non-DAC timing differences

  • Anyone expecting large results from solo use without adjusting expectations

Add to Cycle Builder Read: The Growth Hormone, IGF-1, and Recovery Axis ← Browse